» Articles » PMID: 9389739

Retrograde Inflammatory Signaling from Neutrophils to Endothelial Cells by Soluble Interleukin-6 Receptor Alpha

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1998 Feb 12
PMID 9389739
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Endothelial cells initiate the inflammatory response by recruiting and activating leukocytes. IL-6 is not an agonist for this, but we found soluble IL-6 receptor alpha-subunit (IL-6Ralpha), with their constitutive IL-6 synthesis, stimulated endothelial cells to synthesize E-selectin, intracellular adhesion molecule-1, vascular cellular adhesion molecule-1, IL-6, and IL-8, and to bind neutrophils. Neutrophils express significant amounts of IL-6Ralpha and upon stimulation shed it: this material activates endothelial cells through a newly constituted IL-6 receptor. Retrograde signaling from PMN activated in the extravascular compartment to surrounding endothelial cells will recruit more and a wider variety of leukocytes. The limiting signal is a soluble receptor, not a cytokine.

Citing Articles

Exploring the Role of Hormones and Cytokines in Osteoporosis Development.

Umur E, Bulut S, Yigit P, Bayrak E, Arkan Y, Arslan F Biomedicines. 2024; 12(8).

PMID: 39200293 PMC: 11351445. DOI: 10.3390/biomedicines12081830.


Balancing the Scales: The Dual Role of Interleukins in Bone Metastatic Microenvironments.

Dawalibi A, Alosaimi A, Mohammad K Int J Mol Sci. 2024; 25(15).

PMID: 39125732 PMC: 11311339. DOI: 10.3390/ijms25158163.


Comprehensive analyses of circulating cardiometabolic proteins and objective measures of fat mass.

Titova O, Brunius C, Warensjo Lemming E, Stattin K, Baron J, Byberg L Int J Obes (Lond). 2023; 47(11):1043-1049.

PMID: 37550405 PMC: 10599989. DOI: 10.1038/s41366-023-01351-z.


The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review.

Xu J, Yu L, Liu F, Wan L, Deng Z Front Immunol. 2023; 14:1222129.

PMID: 37475866 PMC: 10355373. DOI: 10.3389/fimmu.2023.1222129.


Th1 Cells Alter the Inflammatory Signature of IL-6 by Channeling STAT Transcription Factors to Alu-like Retroelements.

Millrine D, Cardus Figueras A, Uceda Fernandez J, Andrews R, Szomolay B, Cossins B J Immunol. 2023; 211(2):274-286.

PMID: 37272871 PMC: 10315439. DOI: 10.4049/jimmunol.2300114.


References
1.
Modur V, Zimmerman G, Prescott S, McIntyre T . Endothelial cell inflammatory responses to tumor necrosis factor alpha. Ceramide-dependent and -independent mitogen-activated protein kinase cascades. J Biol Chem. 1996; 271(22):13094-102. DOI: 10.1074/jbc.271.22.13094. View

2.
Peters M, Jacobs S, Ehlers M, Vollmer P, Mullberg J, Wolf E . The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J Exp Med. 1996; 183(4):1399-406. PMC: 2192475. DOI: 10.1084/jem.183.4.1399. View

3.
Walev I, Vollmer P, Palmer M, Bhakdi S, Rose-John S . Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide. Proc Natl Acad Sci U S A. 1996; 93(15):7882-7. PMC: 38843. DOI: 10.1073/pnas.93.15.7882. View

4.
Vollmer P, Walev I, Rose-John S, Bhakdi S . Novel pathogenic mechanism of microbial metalloproteinases: liberation of membrane-anchored molecules in biologically active form exemplified by studies with the human interleukin-6 receptor. Infect Immun. 1996; 64(9):3646-51. PMC: 174276. DOI: 10.1128/iai.64.9.3646-3651.1996. View

5.
Zimmerman G, McIntyre T, Prescott S . Adhesion and signaling in vascular cell--cell interactions. J Clin Invest. 1996; 98(8):1699-702. PMC: 507606. DOI: 10.1172/JCI118967. View